The STOP CCP Act of 2025 prohibits U.S. persons from investing in publicly traded securities of Chinese entities involved in defense or surveillance technology and expands the list of sanctioned military-linked companies while mandating the automatic application of all relevant sanctions against targeted entities.
Rick Scott
Senator
FL
The STOP CCP Act of 2025 prohibits U.S. persons from investing in publicly traded securities of specific Chinese entities involved in defense or surveillance technology. This legislation mandates the expansion of the Treasury Department's list of Chinese military-industrial complex companies and closes loopholes by automatically applying all relevant sanctions when a Chinese entity is targeted under any existing authority. The goal is to prevent U.S. capital from financing pernicious Chinese companies and policies.
The new Sanction Transactions Originating from Pernicious Chinese Companies and Policies Act of 2025—or the STOP CCP Act—is a major play to cut off U.S. capital from certain Chinese companies. At its core, the bill bans U.S. persons from buying or selling the publicly traded stocks (or anything related, like derivatives) of Chinese entities that the Treasury Secretary identifies as operating in China's defense industry or surveillance technology sectors. This isn't just about big institutional investors; if you own a mutual fund or an ETF that holds shares in one of these targeted companies, you’re going to feel the ripple effects of required divestment.
Section 3 is the one that hits your pocketbook directly. The Secretary of the Treasury, working with State and Defense Departments, gets the power to name and shame companies tied to China’s defense or surveillance tech. Once a company is on this list, any "United States Person"—which includes every U.S. citizen, green card holder, or company incorporated here—is banned from trading their publicly traded securities. If you’re a financial advisor, this means you can’t service these transactions, and if you’re an everyday investor, it means those assets become toxic overnight, requiring rapid divestment. This move is designed to starve the targeted sectors of American funding, but it creates a compliance headache for every financial firm and fund manager dealing in global equities.
Section 4 expands the government’s existing blacklist of companies tied to the Chinese military-industrial complex. Currently, the list targets specific entities, but this bill forces the Treasury Department to sweep up four new categories of companies. This includes any business that supports the complex, any company owned or controlled by that supporter, any successor company that spun off from a listed entity, and any financial services provider that helps fund any of the above. Think of it like this: if a bank helps finance a company on the blacklist, that bank could now end up on the blacklist itself. This drastically expands the net and makes global financial institutions—even those outside the U.S.—vulnerable to being caught in the crossfire just for providing routine services.
Perhaps the most impactful, and potentially chaotic, part of the bill is Section 5, which aims to close "sanctions loopholes." This section mandates that if a Chinese entity is sanctioned under one specific law or executive order, it must automatically be sanctioned under all other applicable U.S. laws and orders simultaneously. This creates an immediate, cascading effect. Instead of a targeted sanction under one authority, the entity instantly faces the maximum possible penalty under every relevant legal framework. For financial institutions and global businesses, this means the risk profile of any transaction involving a Chinese entity skyrockets. A minor violation under one law could instantly trigger a massive, multi-layered regulatory crisis, creating extreme compliance burdens and potentially disrupting global supply chains that rely on these newly targeted firms. The President can issue a national security waiver to stop this domino effect, but they have to report the decision to Congress 20 days in advance with a detailed explanation, which puts a public spotlight on any attempt to ease the restrictions.